Skip to main content
Caplight Logo









Innoventric

Innoventric

Private
Ness ZionaHealthcare & Life Scienceshttps://innoventric.com/

Last Round

Series B

Oct 29, 2024

Total Funding Raised

$42.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Innoventric is a medical device company that develops transcatheter solutions for the treatment of tricuspid regurgitation and right heart disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

tricuspid regurgitationtranscatheter valve replacementstructural heartcross-caval technologyminimally invasive surgerymedical deviceinterventional cardiologypercutaneous valveTAVRvalve replacementcardiovascular implantclinical trialsstructural heart diseaseheart valve repair

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Innoventric Comparables

Compare Innoventric with similar companies based on industry and business-model similarity.

Innoventric comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
P&F Products & Features GmbH
91%
CroíValve
89%
VDyne
87%

Innoventric Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 29, 2024
Series ANov 1, 2021

Key People

Founding team and executive leadership

Einat Har

Chief Financial Officer

Executive Team

Innoventric Investors

Notable investors and investment history

Innoventric investors
InvestorRounds
European Innovation Council FundSeries B, Series A
RA Capital ManagementSeries B
BRM GroupSeed, Series A, Series B
Mivtach Shamir HoldingsSeries B, Seed, Series A
JG InvestmentSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors grew 677% MoM, from 189 to 1.5K.

  • Oct 29, 2024

    $29M round led by RA Capital Management.

Innoventric Filings

Explore SEC and related filing metadata, where available.

Innoventric filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Innoventric's valuation, stock price, and market status.

Is Innoventric a public or private company?

Innoventric is a private company.

What is the current stock price of Innoventric?

Innoventric is a private company with no public stock price. No recent secondary market data is available.

How much is Innoventric worth (valuation)?

Valuation information for Innoventric is not publicly available.

Can I buy Innoventric stock?

Innoventric shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Innoventric's last funding round?

Innoventric's most recent funding round was Series B on October 29, 2024.

Who are the main investors in Innoventric?

Key investors in Innoventric include European Innovation Council, RA Capital Management.

Will Innoventric IPO soon?

No public IPO plans have been announced for Innoventric.

How can I track Innoventric secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Innoventric's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNess Ziona
Employee Range17
Year Founded2017
Last FundingOct 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?